A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease

NCT01503736 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

183

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperphosphatemia
End Stage Renal Disease
ESRD

Interventions

DRUG: ferric citrate
DRUG: ferric citrate
DRUG: ferric citrate

Sponsor

Panion & BF Biotech Inc.